NewAmsterdam Pharma Co N.V.

NAMS · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $3.3B · 100 employees
86
SEC Filings
$31.79
Close 2026-06-01
100
Employees

Business Summary

PART I Overview We are a late-stage biopharmaceutical company whose mission is to improve patient care in populations with cardiometabolic diseases where currently approved therapies have not been adequate or well tolerated. We seek to fill a significant unmet need for a safe, well tolerated and convenient low-density lipoprotein cholesterol (LDL-C) lowering therapy. In multiple Phase 3 trials, we have investigated obicetrapib, an oral, low-dose, once-daily, highly selective cholesteryl ester tr...

Latest Stock Quote

NAMS 2026-06-01 $31.79 O:$33.12 H:$33.245 L:$31.69 Vol:1.9M VWAP:$32.1675
origin leaf: 669d05a1239e9be2f9142209b0be40b94453dff026a96c08e97a9a390f0acaeb

Next Earnings

Q2 FY2026 — expected 2026-09-13

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-182025-12-310001193125-26-056029EDGAR133K words
2025-02-262024-12-310000950170-25-027339EDGAR—
2024-02-282023-12-310000950170-24-021668EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-052025-09-300001193125-25-265796EDGAR24K words
2025-08-062025-06-300000950170-25-103521EDGAR—
2025-05-082025-03-310000950170-25-066413EDGAR—
2024-11-062024-09-300000950170-24-121828EDGAR—
2024-08-072024-06-300000950170-24-092281EDGAR—
2024-05-082024-03-310000950170-24-055767EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-020001193125-26-084266EDGAR1K words
2026-02-180001193125-26-056020EDGAR—
2026-01-090001193125-26-008300EDGAR—
2025-11-050001193125-25-265800EDGAR—
2025-09-020000950170-25-112345EDGAR—
2025-08-180000950170-25-109567EDGAR—
2025-08-150000950170-25-109387EDGAR—
2025-08-060000950170-25-103520EDGAR—
2025-07-300000950170-25-099891EDGAR—
2025-07-110001193125-25-158211EDGAR—

86 total filings indexed. 67 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001936258
TickerNAMS
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedP7
Websitehttps://www.newamsterdampharma.com
Listed2022-11-23

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 63bf3d89fdeae9b4da9102217fee2ba2faeddb4667cda2b4a2e81ffacfe0b235
parent: 72a49a96e0ebbeef2387d251b2323709b0e9080882ce62d29eed3eb53cfc79de
content hash: 345c27642b5c419d3ae6698022ece5787212ba4bd362b796fec7271aa46ce145
signed: 2026-06-02T19:01:59.266Z
sources: 10 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf